Chen Fu
Impact in
-
- Thyroid Cancer Diagnosis and Treatment
- Neurology top 10%
- Neuroinflammation and Neurodegeneration Mechanisms
- Neurological Disease Mechanisms and Treatments
Papers in
-
- Dementia and Cognitive Impairment Research 5
- Oncology 7
- Cancer Immunotherapy and Biomarkers 2
- Colorectal Cancer Screening and Detection 2
- Co-authors
- Shaojiao Liu (2 shared papers)Xuemei Liu (2 shared papers)Zhang Yunling (2 shared papers)Yifan Wu (1 shared paper)Menghan Liu (1 shared paper)Ling‐Feng Wang (1 shared paper)Hong Zheng (7 shared papers)Bi‐Cheng Wang (5 shared papers)
- Journals
- Journal of Chinese Integrative Medicine (2 papers)Medicine (2 papers)Cancer Medicine (2 papers)Psychogeriatrics (1 paper)BMC Infectious Diseases (1 paper)
- Partner nations
- ChinaHong KongSwitzerland
In The Last Decade
Chen Fu
31 papers receiving 936 citations
Chen Fu's Hit Papers
Peers
Comparison fields: 5 of 87
- Endocrinology, Diabetes and Metabolism 270
- Neurology 79
- Cancer Research 116
- Health Informatics 10
- Complementary and alternative medicine 50
Countries citing papers authored by Chen Fu
This map shows the geographic impact of Chen Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen Fu more than expected).
Fields of papers citing papers by Chen Fu
This network shows the impact of papers produced by Chen Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen Fu. The network helps show where Chen Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chen Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Rehmannioside A improves cognitive impairment and alleviates ferroptosis via activating PI3K/AKT/Nrf2 and SLC7A11/GPX4 signaling pathway after ischemia Hit paper breakdown → | 2022 | 276 |
| 2 | 2020 | 241 | |
| 3 | 2020 | 65 | |
| 4 | 2017 | 41 | |
| 5 | 2020 | 40 | |
| 6 | 2019 | 30 | |
| 7 | 2019 | 26 | |
| 8 | 2017 | 22 | |
| 9 | 2017 | 21 | |
| 10 | 2016 | 20 | |
| 11 | 2021 | 19 | |
| 12 | 2020 | 18 | |
| 13 | 2019 | 16 | |
| 14 | 2017 | 16 | |
| 15 | 2017 | 13 | |
| 16 | 2022 | 12 | |
| 17 | 2022 | 11 | |
| 18 | 2021 | 9 | |
| 19 | 2024 | 9 | |
| 20 | 2023 | 8 |
About Chen Fu
Chen Fu is a scholar working on Psychiatry and Mental health, Oncology, Complementary and alternative medicine, Otorhinolaryngology and Endocrinology, Diabetes and Metabolism, having authored 33 papers that have together received 952 indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (5 papers), Traditional Chinese Medicine Studies (3 papers), Head and Neck Cancer Studies (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Colorectal Cancer Screening and Detection (2 papers), Thyroid Cancer Diagnosis and Treatment (2 papers) and Traditional Chinese Medicine Analysis (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (270 citations), Neurology (79 citations), Cancer Research (116 citations), Health Informatics (10 citations) and Complementary and alternative medicine (50 citations). Chen Fu has collaborated with scholars based in China, Hong Kong and Switzerland. Frequent co-authors include Shaojiao Liu, Xuemei Liu, Zhang Yunling, Yifan Wu, Menghan Liu, Ling‐Feng Wang, Hong Zheng, Bi‐Cheng Wang, Fengli Wang and Baoxin Chen. Their work appears in journals such as Journal of Chinese Integrative Medicine, Medicine, Cancer Medicine, Psychogeriatrics and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.